Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion

David Round Analyst Performance

Analyst at Argus

David Round is a stock analyst at Argus focused in the energy sector, covering 4 publicly traded companies. Over the past year, David Round has issued 1 stock ratings, including and hold recommendations. While full access to David Round's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Round's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
7 Last 9 Years
Buy Recommendations
85.71% 6 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy85.7%6 ratings
Hold14.3%1 ratings
Sell0.0%0 ratings

Out of 7 total stock ratings issued by David Round at Argus, the majority (85.7%) have been Buy recommendations, followed by 14.3% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
75.0% of companies on NYSE
3 companies
OTCMKTS
25.0% of companies on OTCMKTS
1 company

David Round, an analyst at Argus, currently covers 4 companies listed on NYSE and OTCMKTS, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Energy
3 companies
75.0%
Healthcare
1 company
25.0%

David Round of Argus specializes in stock coverage within the Energy sector, with additional focus on Healthcare companies.

Coverage Industries

IndustryPercentage
OIL, GAS & CONSUMABLE FUELS
3 companies
75.0%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
25.0%

David Round's Ratings History at Argus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Abbott Laboratories stock logo
ABT
Abbott Laboratories
10/27/2026Downgrade$104.72Hold